These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 650663)

  • 1. Synthesis of O-alkylated lysine-vasopressins, inhibitors of the antidiuretic response to lysine-vasopressin.
    Larsson LE; Lindeberg G; Melin P; Pliska V
    J Med Chem; 1978 Apr; 21(4):352-6. PubMed ID: 650663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiuretic agonism and antagonism of some O-alkylated analogues of vasopressin containing 2-O-alkylated tyrosine.
    Melin P; Lundin S; Vilhardt H; Lindeberg G; Larsson LE; Pliska V
    Eur J Pharmacol; 1980 Oct; 67(2-3):173-7. PubMed ID: 7461030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and some pharmacological properties of (3-beta-(2-thienyl)-L-alanine)-8-lysine-vasopressin.
    Smith CW; Ferger MF; Chan WY
    J Med Chem; 1975 Aug; 18(8):822-5. PubMed ID: 1171984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid phase synthesis and some pharmacological properties of 8-D-homolysine-vasopressin and 1-deamino-8-D-homolysine-vasopressin.
    Gunnar E; Lindeberg G
    Int J Pept Protein Res; 1975; 7(5):395-401. PubMed ID: 1184288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activation of synthetic hormonogens of lysine vasopressin: Na-glycyl-glycyl-glycyl-[8-lysine]vassopressin in the cat.
    Pliska V; Chard T; Rudinger J; Forsling ML
    Acta Endocrinol (Copenh); 1976 Mar; 81(3):474-81. PubMed ID: 946340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiuretic and pressor activities of vasopressin analogs with L-alaninamide and D-alaninamide substitutions at position 9.
    Buku A; Gazis D; Schwartz IL
    Int J Pept Protein Res; 1984 May; 23(5):551-7. PubMed ID: 6547408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of vasopressin-glycine and vasopressin-glycine-lysine-arginine on renal function in the rat.
    Lote CJ; McVicar AJ; Smyth DG
    J Endocrinol; 1986 Feb; 108(2):255-60. PubMed ID: 3950530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model for the study of the oral administration of peptide hormones.
    Saffran M; Franco-Saenz R; Kong A; Papahadjopoulos D; Szoka F
    Can J Biochem; 1979 Jun; 57(6):548-53. PubMed ID: 314322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid phase synthesis and some pharmacological properties of 8-D-homoarginine-vasopressin and 1-deamino-8-D-homoarginine-vasopressin.
    Gunnar E; Lindeberg G; Melin P; Larsson LE
    Int J Pept Protein Res; 1976; 8(2):193-8. PubMed ID: 1270191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [5-(N4,N4-Dimethylasparagine),8-lysine]vasopressin: the first 5-position neurohypophyseal hormone analogue to retain to retain significant antidiuretic potency.
    Smith CW; Walter R; Stavropoulos G; Theodoropoulos D
    J Med Chem; 1980 Feb; 23(2):217-9. PubMed ID: 7359538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of more potent antagonists of the antidiuretic responses to arginine-vasopressin.
    Manning M; Olma A; Klis WA; Kolodziejczyk AM; Seto J; Sawyer WH
    J Med Chem; 1982 Jan; 25(1):45-50. PubMed ID: 7086821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
    Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
    Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis.
    Berson BS; Berntson GG; Zipf W; Torello MW; Kirk WT
    Endocrinology; 1983 Jul; 113(1):337-43. PubMed ID: 6861706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actions of antidiuretic hormone analogues on intact and nystatin-permeabilized frog skins.
    Jared SR; Rao JP; Subramani S
    Exp Physiol; 2009 Dec; 94(12):1174-84. PubMed ID: 19666695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities of some new arginine vasopressin analogues containing unusual amino acids.
    Varga C; Somlai C; Baláspiri L; László FA
    Acta Physiol Hung; 1993; 81(2):183-92. PubMed ID: 8197874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activities of a fluorescent photoaffinity analog of vasopressin.
    Buku A; Schwartz IL; Gazis D; Ma CL; Eggena P
    Endocrinology; 1985 Jul; 117(1):196-200. PubMed ID: 3924578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
    Yu H; Zhuge R; Hsu WH
    Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.